Delivery Order SPE2DB20D9127-SPE2DB25FPRG6
- Not listed
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for ZOSYN 3.375 GM/50 ML Galaxy 50ML with a ceiling value of $1,351.60. This delivery order, issued on August 6, 2025, with an ultimate completion date of August 27, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. The award is issued under DMS Pharmaceutical Group's larger single-award...
- The Defense Logistics Agency awarded a delivery order valued at $1,612.38 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Zosyn 3.375 GM/50 ML Galaxy 50ML vials. The contract was awarded on September 26, 2025, with an ultimate completion date of October 20, 2025, and carries a firm fixed-price structure with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, a delivery order valued at $1,554.00 for ZOSYN 4.5 GM/100 ML Galaxy Bag 100ML on July 24, 2025. The contract utilizes firm fixed-price pricing with an ultimate completion date of August 14, 2025, and specifies Park Ridge, Illinois as the place of performance. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA, a...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Zosyn 3.375 GM/50 ML Galaxy 50ML with a ceiling value of $1,351.60. The award, issued on August 20, 2025, with an ultimate completion date of September 11, 2025, utilizes a firm fixed-price contract type. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $1,544.85 to DMS Pharmaceutical Group Inc. for the supply of Zosyn 4.5 GM/100 ML Galaxy Bag in 100 ML units. This delivery order, issued on September 18, 2025, with an ultimate completion date of October 9, 2025, represents a firm fixed-price contract with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Park...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,315.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on September 16, 2025. This firm fixed-price delivery order, with an ultimate completion date of October 7, 2025, covers the supply of ZOSYN 4.5 GM/100 ML in Galaxy bag format (100 ML units). The contract was issued without a set-aside designation, and performance will take place at the vendor's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a firm fixed-price delivery order from the Defense Logistics Agency (DLA) valued at $1,000.32 for ZOSYN 3.375 GM/50 ML Galaxy 50ML pharmaceutical product. The award, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, represents a single delivery order with no set-aside designation. Performance will occur at the contractor's facility in Park...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,486.40 by the Defense Logistics Agency (DLA) on August 12, 2025, for the supply of Zosyn 4.5 GM/100 ML Galaxy Bag 100ML pharmaceutical product. This firm fixed-price delivery order, with an ultimate completion date of September 3, 2025, was issued without a set-aside designation. The contract represents a specific fulfillment under DMS...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at one thousand six hundred sixty-seven dollars and seventy cents ($1,667.70) by the Defense Logistics Agency to supply ZOSYN 3.375 GM/50 ML GALAXY 50ML. The delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to provide pharmaceuticals and medical supplies with a potential value of up to five million dollars through December 2025. As a...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,036.00 to DMS Pharmaceutical Group Inc. on August 29, 2025, for the supply of Zosyn 4.5 GM/100 ML in Galaxy Bag format (100 ML units). This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, a $500 million single-award contract valid through November 2026 that authorizes the issuance of firm fixed-price delivery orders for comprehensive...
- SPE2DB20D9127Indefinite Delivery Contract
- SPE2DB20D9127-SPE2DB25FPRG6Delivery Order
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc. for ZOSYN 3.375 GM/50 ML Galaxy 50ML pharmaceutical product on September 2, 2025, with a ceiling value of $1,621.92. This firm fixed-price delivery order is scheduled for completion by September 23, 2025, and will be performed at the vendor's location in Park Ridge, Illinois. The contract was awarded without a set-aside designation, enabling the woman-owned small business to compete directly in the federal pharmaceutical supply market. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, valued at approximately $500 million and extending through November 2026. As a woman-owned small business pharmaceutical wholesaler, DMS Pharmaceutical Group serves as a critical supplier in the federal pharmaceutical supply chain, providing prescription drugs, biologics, and medical consumables to Department of Defense healthcare facilities nationwide. The company's extensive portfolio of delivery orders demonstrates its established role in supporting military health system supply needs across various therapeutic categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 9/2/25 |